AI assistant
Sending…
Oncopeptides — Major Shareholding Notification 2024
Jun 11, 2024
3091_iss_2024-06-11_54a1ded8-415e-40d4-8717-2d62d8a871a4.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer

Issuer Oncopeptides AB
Holder
Nordnet AB (publ)
Instrument
| Instrument | Aktie SE0009414576 | |
|---|---|---|
| Before the transaction | ||
| Shares | Data not given* | |
| Voting rights | Data not given* | |
| Transaction | ||
| Reason for major shareholding notification Sell | ||
| Date | 10/06/2024 | |
| Limit for number of shares | 5 % | |
| After the transaction | ||
| Quantity | ||
| Shares | 10,720,323 | |
| Directly held voting rights | 0 | |
| Indirectly held voting rights | 10,720,323 | |
| Percentage | ||
| Directly held shares | 4.98188 % | |
| Directly held voting rights | 0 % | |
| Indirectly held voting rights | 5.0701 % |
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
|
|---|---|---|
| Shares | 5.0701 % | 10,720,323 |
| Instruments - FITA Ch. 4, section 2, first paragraph, line 2 Instruments - FITA Ch. 4, section 2, first paragraph, line 3 |
||
| - Physically settled - Cash settled |
||
| Total | 5.0701 % | 10,720,323 |
| Chain of controlling companies Voting rights % Voting rights Company 10,403,564 4.92029 Nordnet Pensionsförsäkring AB 316,759 0.1498 Nordnet Livsforsikring AS |
||
| Group total holdings |
||
| Voting rights 10,720,323 |
||
| Percentage of voting rights 5.0701 | ||
| Published 11/06/2024 14:06 |
||
| Contact | ||
| Name Felix Mandoki |
||
| Phone +46766110734 Email [email protected] |
||
| *Source of information has chosen not to submit the data |
CLOSE PRINT
[email protected] Tfn 08-408 980 37 Fax 08-24 39 25
More from Oncopeptides
Declaration of Voting Results & Voting Rights Announcements
2026
May 21
Declaration of Voting Results & Voting Rights Announcements
2026
May 21
Interim / Quarterly Report
2026
May 13
Interim / Quarterly Report
2026
May 13
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 11
Annual Report
2026
Apr 28
Major Shareholding Notification
2026
Apr 24
Major Shareholding Notification
2026
Apr 21
Proxy Solicitation & Information Statement
2026
Apr 16